Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (51)

2023

  1. What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

    Reumatologia Clinica, Vol. 19, Núm. 1, pp. 26-33

2022

  1. Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry

    Journal of Rheumatology, Vol. 49, Núm. 4, pp. 398-407

  2. Differential diagnosis of arthritis

    Pediatria Integral, Vol. 26, Núm. 3, pp. 125-131

  3. IgA deficiency and autoimmune comorbidities in juvenile idiopathic arthritis

    Anales de Pediatria, Vol. 97, Núm. 3, pp. 172-178

  4. Juvenile dermatomyositis-associated calcinosis successfully treated with combined immunosuppressive, bisphosphonate, oral baricitinib and physical therapy

    Dermatologic Therapy

  5. Morbidity of uveitis associated with juvenile idiopathic arthritis: The silent disease

    Anales de Pediatria, Vol. 97, Núm. 5, pp. 356-358

  6. Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study

    Pediatric Rheumatology, Vol. 20, Núm. 1

  7. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

2021

  1. Hemorrhagic Bullous IgA Vasculitis (Schönlein-Henoch purpura), Does it Have a Worse Prognosis?

    Reumatologia Clinica, Vol. 17, Núm. 9, pp. 549-551

  2. Ventricular Repolarization Parameters and Coronary Involvement in Kawasaki Disease

    Journal of Pediatrics, Vol. 236, pp. 108-112.e5

2020

  1. Juvenile idiopathic arthritis and Turner's syndrome

    Anales de Pediatria, Vol. 93, Núm. 4, pp. 259-261

  2. Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors

    Anales de Pediatria, Vol. 92, Núm. 3, pp. 124-131

  3. Should training in paediatric rheumatology be improved? Results of a national survey

    Anales de Pediatria, Vol. 92, Núm. 3, pp. 165-166

2019

  1. Acquired and innate immunity impairment and severe disseminated Mycobacterium genavense infection in a patient with a NF-κB1 deficiency

    Frontiers in Immunology, Vol. 10, Núm. JAN

  2. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis

    Rheumatology (United Kingdom), Vol. 58, Núm. 7, pp. 1196-1205

  3. Pediatrician Beliefs about Juvenile Idiopathic Arthritis May Result in Referral Delays: A Spanish National Survey

    Journal of Pediatrics, Vol. 209, pp. 236-239.e2

  4. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

    The Lancet Child and Adolescent Health, Vol. 3, Núm. 4, pp. 255-263

  5. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 1, pp. 359-368

2018

  1. Aproximación diagnóstica en uveítis pediátrica

    Acta estrabológica: publicación oficial de la Sociedad Española de Estrabología, Pleóptica, Ortóptica, Visión Binocular, Reeducación y Rehabilitación Visual, Vol. 47, Núm. 1, pp. 67-76

  2. Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care

    Arthritis Care and Research, Vol. 70, Núm. 9, pp. 1312-1319